Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Triplett

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JAMA Psychiatry|March 9, 2018
Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysisChuanjun Zhuo, Patrick Todd Triplett
The British Journal of Psychiatry : the Journal of Mental Science|February 27, 2019
Lung cancer incidence in patients with schizophrenia: meta-analysisChuanjun Zhuo, Hongqing Zhuang, Xiangyang Gao, et al.
Plos One|April 13, 2012
Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expressionWilliam L Redmond, Todd Triplett, Kevin Floyd, et al.
Cancer Metastasis Reviews|September 15, 2020
Current methods in translational cancer researchMichael W Lee, Mihailo Miljanic, Todd Triplett, et al.
Molecular Cancer Therapeutics|August 17, 2022
Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and AutophagyMilad Soleimani, Alexander Somma, Tamer Kaoud, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JAMA Psychiatry|March 9, 2018
Association of Schizophrenia With the Risk of Breast Cancer Incidence: A Meta-analysisChuanjun Zhuo, Patrick Todd Triplett
The British Journal of Psychiatry : the Journal of Mental Science|February 27, 2019
Lung cancer incidence in patients with schizophrenia: meta-analysisChuanjun Zhuo, Hongqing Zhuang, Xiangyang Gao, et al.
Plos One|April 13, 2012
Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expressionWilliam L Redmond, Todd Triplett, Kevin Floyd, et al.
Cancer Metastasis Reviews|September 15, 2020
Current methods in translational cancer researchMichael W Lee, Mihailo Miljanic, Todd Triplett, et al.
Molecular Cancer Therapeutics|August 17, 2022
Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and AutophagyMilad Soleimani, Alexander Somma, Tamer Kaoud, et al.
Pageof 1